BUFFALO, N. Y. -- Teresa Quattrin, MD, University at Buffalo Distinguished Professor of pediatrics, is a co-author on a new global study that suggests a novel treatment option for children with ...

Shares of BridgeBio Pharma rose after the company reported positive results from a Phase 3 study of its oral infigratinib treatment candidate for children with achondroplasia, a genetic condition ...

The daily injectable vosoritide (Voxzogo) appears promising for various genetic causes of short stature in children, new phase 2 trial data suggested. Vosoritide is a C-type natriuretic peptide analog ...

Please provide your email address to receive an email when new articles are posted on . Children with five genetic causes of short stature had height velocity increases of 3 cm or more with vosoritide ...

Sometimes a child's height is influenced by more than just genetics and can be a signal that something else is wrong. Dr. Nancie MacIver of Duke Pediatrics Division of Endocrinology explains how ...

Abnormalities in the short stature homeobox-containing (SHOX) gene cause SHOX syndrome. This condition leads to a short stature and other skeletal differences that develop in the first few years of ...

Rare growth disorders are a diverse group of uncommon conditions that affect an individual’s physical development. They may stem from genetic mutations, hormonal imbalances, or other complex factors.